---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-23-000009"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2023-03-01T23:59:59+00:00"
generated_at: "2026-06-18T17:51:13.080174+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MariMed Q4 revenue up 15.5% YoY to $35.8M; net income turns positive but EBITDA margin shrinks

## Summary
- Q4 revenue $35.8M (+15.5% YoY); full-year revenue $134.0M (+10.3% YoY).
- GAAP net income Q4 $4.8M vs loss of $6.4M in prior year; full-year net income $13.6M (+79% YoY).
- Non-GAAP adjusted EBITDA Q4 $4.5M (down 46% YoY); full-year $32.4M (down 24% YoY).
- GAAP gross margin Q4 44% vs 50% prior year; full year 48% vs 55%.
- CEO: positive cash flow from ops for third consecutive year; expects accelerated growth in 2023.

## SEC filing metadata
- accession: 0001522767-23-000009
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2023-03-01T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000009/0001522767-23-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000009/mrmd-20230301.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-23-000009
- JSON: https://secwatch.observer/filing/0001522767-23-000009.json
- Plain text: https://secwatch.observer/filing/0001522767-23-000009.txt

## Key facts
- Earnings Releases
  MARIMED INC. reported year ended December 31, 2022 results: revenue $134.0, net income $13.6.
  - Period: year ended December 31, 2022
  - Revenue: $134.0
  - Net income: $13.6
  - Result: reported results
  source text: 2022 and 2021 (in millions, except percentage amounts): Financial Highlights 1 Three months ended Year ended December 31, December 31, 2022 2021 2022 2021 Revenue $ 35.8 $ 31.0 $ 134.0 $ 121.5 GAAP Gross margin 44 % 50 % 48 % 55 % Non-GAAP Gross margin 45 % 50 % 48 % 55 % GAAP Net income (loss) $ 4.8 $ (6.4) $ 13.6 $ 7.6 Non-GAAP Net income $ 5.2 $ 0.1 $ 22.2 $
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000009/0001522767-23-000009-index.htm
- Earnings Releases
  MARIMED INC. reported three months ended December 31, 2022 results: revenue $35.8, net income $4.8.
  - Period: three months ended December 31, 2022
  - Revenue: $35.8
  - Net income: $4.8
  - Result: reported results
  source text: December 31, 2022 and 2021 (in millions, except percentage amounts): Financial Highlights 1 Three months ended Year ended December 31, December 31, 2022 2021 2022 2021 Revenue $ 35.8 $ 31.0 $ 134.0 $ 121.5 GAAP Gross margin 44 % 50 % 48 % 55 % Non-GAAP Gross margin 45 % 50 % 48 % 55 % GAAP Net income (loss) $ 4.8 $ (6.4) $ 13.6 $ 7.6 Non-GAAP Net income $ 5.2
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000009/0001522767-23-000009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.